KN Group – a leading UK telecommunications, power and transport infrastructure company are delighted to announce their new charity partnerships with Prostate Cancer UK and Ovarian Cancer Action.
KN Group rely on innovation, research and design in their day to day business, and as such are proud to support the efforts of both charities in order to help raise money for research and awareness of both diseases.
KN Group’s staff will be raising funds through a year-long partnership with a programme of on-going activities, ranging from staff bake days to marathons and cycling events. All fundraising activities and events are designed for both individual staff members and groups, in order to have the biggest impact and get as many people at KN Group involved as possible, as well as to engage with communities local to their offices.
KN Group intend to spread the message about Prostate Cancer UK and Ovarian Cancer Action far and wide as they work across the length and breadth of the UK, with information readily available about the charities at KN Group locations as well as through links on their website.
KN Group are hopeful that a collaborative approach to raising funds and spreading the message about both prostate cancer and ovarian cancer will provide valuable support in the efforts against these diseases.
Oliver Chatten, Managing Director of KN Group UK said: “We are delighted to be helping to raise awareness across the UK for both charities in their excellent efforts to support, treat, research and diagnose ovarian and prostate cancer, which affects the lives of so many, not just those who are undergoing treatment but also their families. With our company commitment and the great enthusiasm of our staff, we believe we can achieve a great deal over the next year and beyond in supporting these great causes.”
James Beeby, Director of Fundraising at Prostate Cancer UK said: “A huge thank you to everyone at KN Group who voted for Prostate Cancer UK to become one of their chosen charities. By taking part in a whole range of activities, KN Group are helping us to raise funds for vital research into better diagnosis, treatment and support for men. As well as this, the partnership will create opportunities to spread an important health message to KN Group employees and through their work across the UK. This will help us to make sure even more men are thinking about their health and continue our ambition to stop prostate cancer being a killer.”
Cary Wakefield, Chief Executive of Ovarian Cancer Action said: “We’re thrilled KN Group has chosen to support Ovarian Cancer Action and in turn, the 7,300 women diagnosed with ovarian cancer each year. KN Group will help fund our research to provide better diagnosis, treatment and survival for women with ovarian cancer, as well as utilising its network across the UK to spread symptom awareness; the four main symptoms of ovarian cancer are persistent stomach pain, persistent bloating, feeling full quickly and needing to wee more often. Early detection increases a woman’s chances of survival – thank you to everyone at the KN Group for your help.”
Notes to Editors
About Prostate Cancer UK
Prostate Cancer UK leads the fight against prostate cancer. We fund ground-breaking research, drive improvements in treatment, and fight injustice in care. Now we’ve set ourselves the toughest challenge yet: to stop prostate cancer being a killer.
Through shifting the science over the next 10 years to focus on radical improvements in diagnosis, treatment, prevention and support, we can make prostate cancer a disease the next generation of men need not fear.
Key headline statistics
- 11,000 men die from prostate cancer in the UK each year. That’s one man every forty-five minutes.
- It’s the most common cancer in men, with 400,000 living with and after the disease in the UK. 1 in 8 men in the UK will be diagnosed with prostate cancer. The stats are 1 in 4 in black men.
- Prostate cancer is set to become the most commonly diagnosed cancer of all in the UK in 2030 – which is why we must all act now to curb its power to kill.
- Prostate cancer treatment often causes devastating, long term side-effects. Incontinence and erectile dysfunction strike at the heart of what it means to be a man.
- Anyone with concerns about prostate cancer may contact Prostate Cancer UK’s Specialist Nurses in confidence on 0800 074 8383 or online via the Live Chat instant messaging service: prostatecanceruk.org. The Specialist Nurse phone service is free to landlines and open from 9am to 6pm Monday to Friday with late opening until 8pm on Wednesdays.
- Visitprostatecanceruk.org now to help beat this disease.
About Ovarian Cancer Action
Ovarian Cancer Action is the UK’s ovarian cancer research charity and its mission is to fund research that saves lives. From funding scientists on the front line, to mobilising millions of people across the UK to take action. Ovarian Cancer Action is driven by a vision of a world without ovarian cancer and a belief that it can create a better future.
Key headline statistics
- Ovarian cancer is the sixth most common cancer in women.
- 4,200 women die from ovarian cancer each year. That’s one woman every two hours.
- Around 7,300 women are diagnosed with ovarian cancer each year. Less than half will survive beyond five years.
- The UK has the worst survival rate of ovarian cancer in Europe.
- 1 in 4 women believes that a cervical smear test detects ovarian cancer. It doesn’t.
- For more information on ovarian cancer and how you can help, visit: ovarian.org.uk.